Enjoy complimentary customisation on priority with our Enterprise License!
The oncology molecular diagnostics market size is forecast to increase by USD 3.95 billion at a CAGR of 13.64% between 2023 and 2028. The market is experiencing significant growth due to the increasing prevalence of cancer globally. This sector is witnessing the integration of advanced technologies like next-generation sequencing (NGS), chips, and microarrays in clinical testing and clinical trials. The adoption of these technologies is enabling early and accurate diagnosis of diseases such as cervical and colorectal cancer. However, the unfavorable reimbursement scenario poses a challenge to market growth. Dietary changes and lifestyle modifications are also contributing factors influencing the market dynamics. The market is expected to grow steadily due to the increasing focus on personalized medicine and the availability of government funding for cancer research.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.